Revolutionizing Addiction Treatment with GLP-1 Agonists: A New Frontier in Opioid Craving Reduction

In a groundbreaking development, GLP-1 medication, specifically liraglutide, has shown remarkable potential in reducing opioid cravings, according to a small yet significant study. This marks the first-ever randomized controlled trial testing anti-obesity drugs against opioid addiction, a condition claiming the lives of approximately 80,000 individuals in the U.S. annually. The study, presented at the American …

superbakrill

Asian Ingredients Awards 2023 Shortlist (Cos&Beauty)

NutraIngredients recently released the shortlist for the 2023 Asia Ingredients Awards, which aims to encourage innovation and cutting-edge research in the fields of functional foods, dietary supplements, and nutritional ingredients. The award categories include oral beauty, cognitive function, microbiome regulation, sports nutrition, weight management, and healthy aging, with the following lists of finalists in each …